Download FREE Report Sample
Download Free sampleRNA interference is a relatively new concept in the field of medicine. It is a process in which the ribonucleic acid inhibits translation or gene expression by converting single-stranded mRNA to double stranded RNA, thereby neutralizing the target nucleic acids.
RNAi Technology Market contains market size and forecasts of RNAi Technology in Global, including the following market information:
Global RNAi Technology Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global RNAi Technology market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cancer Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of RNAi Technology include Alnylam Pharmaceuticals, Dicerna Pharmaceuticals, Inc., Arrowhead Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., Quark Pharmaceuticals, Inc., Arbutus Biopharma, Benitec Biopharma, Calando and Silence Therapeutics and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the RNAi Technology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global RNAi Technology Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global RNAi Technology Market Segment Percentages, by Type, 2021 (%)
Cancer
Liver Disorders
Respiratory Disorders
Neurological Disorders
Autoimmune Disorders
Others
Global RNAi Technology Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global RNAi Technology Market Segment Percentages, by Application, 2021 (%)
Drug Discovery & Development
Therapeutics
Drug Delivery
Others
Global RNAi Technology Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global RNAi Technology Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies RNAi Technology revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies RNAi Technology revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alnylam Pharmaceuticals
Dicerna Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc.
Arbutus Biopharma
Benitec Biopharma
Calando
Silence Therapeutics
Gotham Therapeutics
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
